Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantation.

Conclusions: The intravenous/intratheca administration of donor CMV-specific CTLs may be a safe and effective treatment for CMV encephalitis, especially for patients who suffered from drug-resistant CMV infection. PMID: 31906810 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31906810?dopt=Abstract

Source: Hematology - January 9, 2020 Category: Hematology Tags: Hematology Source Type: research